This promotional animation has been commissioned and funded by Reckitt and developed in partnership with Guidelines in Practice. See below for full disclaimer.
Information intended for healthcare professionals only.
Cow’s milk allergy, or CMA, is the most common food allergy in young children,1 affecting around 1.8–7.5% of infants in their first year of life.2
In this animation Bianca Parau, Specialist Paediatric Dietician, discusses the symptoms and management of cow’s milk allergy, the allergic march, and the latest data on the extensively hydrolysed formula (eHF) Nutramigen LGG®.
Currently, Nutramigen LGG® is the only scientifically proven eHF to help stop the domino effect around the allergic march whilst helping infants return infants to cow’s milk faster.1,3–5
- Nocerino R et al. The Impact of Formula Choice for the Management of Pediatric Cow’s Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study. J Pediatr, 2021; 232: 183–91
- NICE. Clinical Knowledge Summaries: Cow’s milk allergy in children. NICE, 2019. Available at: https://cks.nice.org.uk/topics/cows-milk-allergy-in-children/ (accessed August 2021
- Canani R et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow’s milk allergy: 3-year randomized controlled trial. Clin Immunol. 2017; 139(6): 1906–1913
- Canani R et al. Formula Selection for Management of Children with Cow’s Milk Allergy Influences the Rate of Acquisition of Tolerance: A Prospective Multicenter Study. J Pediatr, 2013; 163: 771–777
- Canani R et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol, 2012; 129: 580–582
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Reckitt Benckiser Healthcare (UK) Ltd on: 01895 230575
IMPORTANT NOTICE: Breastfeeding is best for babies. The decision to discontinue breastfeeding may be difficult to reverse and the introduction of partial bottle-feeding may reduce breast milk supply. The financial benefits of breastfeeding should be considered before bottle-feeding is initiated. Failure to follow preparation instructions carefully may be harmful to the health of the baby. Parents should always be advised by an independent healthcare professional regarding infant feeding.
Nutramigen LGG® is a food for special medical purposes for the dietary management of cow’s milk allergy and must be used under medical supervision. Nutramigen LGG® is not recommended for premature and immunocompromised infants unless directed and supervised by a healthcare professional.
Trademark of Mead Johnson & Company, LLC. © 2020 Mead Johnson & Company, LLC. All rights reserved. LGG® is a registered trademark of Chr. Hansen A/S.
This animation has been commissioned and funded by Reckitt and developed in partnership with Guidelines in Practice. Reckitt suggested the topic and presenter, wrote the script, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the presenter. The views and opinions expressed in the animation are not necessarily those of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this animation may be reproduced in any form without the permission of the publisher.
Date of preparation: November 2021